Indian Markets Post Market Report-Apr 23, 2026

📉 Indian Markets Post Market Report Today (Apr 23, 2026)

Indian Markets Post Market Report Today: Indian markets ended lower on Thursday and extended the pullback for a second straight session. The biggest pressure point was still the rise in crude oil above the $100 zone after fresh disruption in the Strait of Hormuz and no visible progress in U.S.–Iran talks. That macro pressure was made worse by rupee weakness, continued caution in financials and autos, and another soft session for IT.

Broader market action was also weak, though not as bad as the benchmark damage suggested earlier this week. Reuters reported the small-cap index fell 0.7% and the mid-cap index slipped 0.4%, while Moneycontrol’s closing breadth showed about 1,688 shares advanced, 2,409 declined, and 155 were unchanged. That means the market weakness was broad enough to hurt sentiment across the board, not just a few heavyweight names.

📊 Indian Markets Post Market Report Today’s Closing Levels

Nifty 50: 24,173.05, down 205.05 points (-0.84%)
Sensex: 77,664.00, down 852.49 points (-1.09%)
Bank Nifty: 56,305.00, down 819.45 points (-1.43%)

🔍 Indian Markets Post Market Report: Reasons for Market Movement Today

1) 🛢️ Crude oil climbed above $100 again

This remained the biggest market trigger. Reuters reported Brent rose above $103 a barrel during the day as U.S.–Iran talks stayed stalled and shipping in the Strait of Hormuz remained disrupted. For India, this is a direct negative because higher oil usually means pressure on inflation, margins, the rupee, and overall market sentiment.

2) 💵 Rupee weakness added to the pressure

The rupee fell for a fourth straight session and closed at 94.1050 per U.S. dollar, its worst losing streak in roughly three months. Reuters said the currency has now fallen more than 1% this week, largely because crude has risen nearly 15% over that period.

3) 🏦 Financials stayed under pressure

Reuters said heavyweight financials fell 1.4%, led by a 1.4% decline in ICICI Bank and a 1.9% loss in HDFC Bank. Because financials carry so much index weight, this kept the broader market from recovering meaningfully during the session.

4) 🚗 Auto stocks were among the worst hit

The auto index dropped 2.4%, making it the worst-performing major sector in Reuters’ market wrap. Rising oil prices tend to hurt the auto narrative because they raise fuel-cost sensitivity and weaken risk appetite in cyclical sectors.

5) 💻 IT stayed weak

Wednesday’s HCLTech shock continued to hang over the sector, and Reuters noted Infosys closed 2.2% lower ahead of its results while the IT index fell 1.2% on the day. So even though the sharpest HCLTech pain was seen a day earlier, the sector still failed to provide support today.

6) 🌍 Geopolitical risk stayed unresolved

Iran’s seizure of two ships and the lack of progress in peace talks kept investors from buying dips aggressively. Reuters and HSBC both highlighted that foreign investors remain uneasy about India because of the oil shock, rupee weakness, and the uncertain global backdrop.

📌 Existing Levels to Watch

Nifty 50

Immediate support: 24,200
Next support zone: 24,100–23,900
Immediate hurdle: 24,500–24,600
Bigger resistance area: 25,000 remains the major short-term ceiling in options data commentary.

Bank Nifty

Immediate support: 55,800
Positional support: 55,000
Immediate resistance: 56,500

Moneycontrol’s post-session technical commentary said the overall setup remains cautious, and Bank Nifty now needs to defend the lower support band after today’s sharper cut.

🚀 Top 5 Gainers in Nifty 50

Dr Reddy’s Laboratories: +9.37%
Cipla: +5.63%
Jio Financial Services: +4.26%
Adani Enterprises: +1.73%
Apollo Hospital : +1.55%

The key takeaway from the gainers list is that pharma clearly outperformed. Reuters said the pharma index rose 2.4%, led by Cipla, which jumped after receiving U.S. FDA approval for a generic respiratory drug. That defensive bias makes sense in a high-oil, weak-rupee, risk-off market.

🔻 Top 5 Losers in Nifty 50

Trent: -4.13%
Shriram Finance: -3.37%
Tech Mahindra: -2.81%
SBI Life Insurance : -3.01%
M&M: -3.24%

This loser list shows exactly where the pressure was: consumer, financials, and IT. Moneycontrol’s broader closing summary similarly highlighted Trent, M&M, Shriram Finance, SBI Life Insurance, and Tech Mahindra among the biggest drags.

🏦 Indian Markets Post Market Report Today’s Sector Performance

Today’s sector picture was mixed, but the weak side clearly dominated:

Auto: down about 2.36%
Financials: down about 1.4%
IT: down about 1.2%
Healthcare / Pharma: up about 2.11 / 2.36%
Capital Goods: up about 0.4%
Energy: up about 0.25%
Media: up about 0.9%
PSU Bank, Consumer Durables: down about 2%
Realty, Metal, Private Bank: down about 1%

So the market message was simple: defensives and healthcare held up, while autos, banks, and rate-sensitive growth pockets took the real damage.

📉 India VIX

India VIX closed at 18.59, up about 1.58% on the day. That rise shows traders are again pricing in more short-term volatility after the recent crude spike and geopolitical escalation. It is not panic territory yet, but it is clearly a warning sign that the market is still uncomfortable.

🌱 Two Growth Stocks from Q4 Results for Investment

1) ICICI Bank

ICICI Bank remains one of the stronger large-cap Q4 stories this season. Reuters reported quarterly net profit rose to ₹137.02 billion, ahead of expectations, while loan growth was 15.8%, deposit growth 11.4%, net interest income up 8.4%, and gross NPA improved to 1.4%. This is a strong combination of growth, profitability, and improving asset quality.

Why it still looks attractive

Strong credit growth
Better bad-loan profile
Earnings beat
Large private-bank leadership

For long-term investors, this kind of Q4 result gives more confidence than simply chasing a one-day mover.

2) Nestle India

Nestle India delivered one of the cleanest consumer-sector Q4 performances so far. Reuters reported Q4 profit rose 26% to ₹1,114 crore, while revenue climbed 23% to ₹6,748 crore on strong demand in products like Maggi and KitKat. Reuters also described this as the strongest domestic growth in nearly a decade, which is a major positive for the FMCG story.

Why it looks attractive

Strong revenue momentum
Good quality FMCG business
Demand-led growth, not only pricing
Capacity expansion plans support future volume growth

This is the kind of result that supports a long-term compounding case in the consumer space.

💸 FII & DII Data

FII & DII Data: Awaited on NSE at the time of publishing.

FII & DII Data (Apr 22, 2026): FIIs were net sellers of ₹2,078.36 crore, while DIIs were net sellers of ₹1,048.17 crore.

🧾 Existing and Upcoming IPO Detailed Updates

Recently closed / post-issue stage

Citius TransNet Investment Trust IPO

Issue size: ₹1,105 crore
Price band: ₹99–₹100
Total subscription: 20.43x
Allotment: Apr 22
Listing expected: Apr 29

Mehul Telecom IPO

Issue size: about ₹27.73 crore
Price band: ₹96–₹98
Total subscription: 41.81x
Allotment: Apr 22
Listing expected: Apr 24

PropShare Celest

Already moved into allotment/listing phase, with listing expected on Apr 24.

Om Power Transmission

Already listed after debuting above issue price earlier this week.

Upcoming IPO to watch

Leapfrog Engineering Services IPO

Open: Apr 23, 2026
Close: Apr 27, 2026
Price band: ₹21–₹23
Issue size: ₹88.51 crore
Lot size: 6,000 shares
Expected listing: Apr 30, 2026

🛢️ Commodity and Currency Market Update

Brent crude: around $102.94 per barrel
WTI crude: around $94.10per barrel
USD/INR: 94.1050
MCX Gold: around ₹1,51,946 per 10 gm
MCX Silver: around ₹2,40,600 per kg

The takeaway is straightforward: oil surged, the rupee weakened, and bullion stayed volatile. That combination is not comfortable for Indian equities, especially when the country is already dealing with foreign outflows and high imported energy costs.

💡 Investment View

Short-term idea: Dr Reddy’s Laboratories

Dr Reddy’s stands out for the short term because it was the top Nifty gainer on a weak market day. When a stock rises sharply while the index falls, that relative strength matters. It also fits the current defensive rotation toward pharma.

Indian Markets Post Market Report Long-term idea: ICICI Bank

For the long term, ICICI Bank still looks stronger because its Q4 result delivered on the three things that matter most: growth, profitability, and asset-quality improvement. That gives it a much better compounding case than a pure one-day tactical pick.

⭐ Stock of the Day: Dr Reddy’s Laboratories

Dr Reddy’s Laboratories is the stock of the day. It was the top Nifty gainer at +8.87% in a market where the index itself fell nearly 1%. That kind of relative strength is worth respecting, especially when pharma was one of the very few sectors that stayed firmly positive.

⚖️ SEBI Updates

A few recent SEBI-side developments remain important for market readers:

SEBI has allowed companies to cut IPO fresh-issue size by up to 50% without refiling, subject to approval, to help issuers deal with volatility linked to the Middle East conflict.
SEBI earlier gave a one-time extension to certain IPO approvals that were nearing expiry, helping issuers wait for better market conditions.
SEBI and the Department of Telecommunications have launched a real-time data-sharing framework to fight securities-market frauds more effectively.
Google has started labeling verified SEBI-registered investment apps on Play Store in India; Reuters said around 600 financial apps had already received the label.

❓ 5 FAQs

1) Why did Indian markets fall today?

Because crude oil jumped above $100, the rupee weakened further, and financials plus autos came under pressure.

2) What was the Nifty 50 closing level on Apr 23, 2026?

Nifty 50 closed at 24,173.05, down 205.05 points or 0.84%.

3) What happened to Bank Nifty today?

Bank Nifty closed at 56,305.00, down 1.43%.

4) Was Apr 23 FII/DII data available on NSE?

At the time of drafting, the same-day official row was not clearly visible, so it is safer to mark it as awaited.

5) Which IPO is the next one to watch?

Leapfrog Engineering Services IPO is the next visible upcoming issue.

Disclaimer:

This article is for educational and informational purposes only. It is not investment advice, not a buy or sell recommendation, and not a substitute for advice from a SEBI-registered investment adviser. Market prices, institutional flows, IPO data, crude oil, precious metals, and currency levels can change quickly. Please verify live data before making any financial decision.